Clinical Trials Logo

Cesarean Section clinical trials

View clinical trials related to Cesarean Section.

Filter by:

NCT ID: NCT06451354 Recruiting - Cesarean Section Clinical Trials

Postoperative Analgesia After Cesarean Section; Comparison Among Ultrasound Guided Erector Spinae, Quadratus Lumborum or Transversus Abdominis Plane Blocks

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The aim of this prospective randomized controlled study is to compare the analgesic efficacy of the ultrasound-guided erector spinae plane block, ultrasound-guided quadratus lumborum plane block, and ultrasound-guided transversus abdominis plane block in patients undergoing elective cesarean section.

NCT ID: NCT06446830 Recruiting - Analgesia Clinical Trials

the Analgesic Efficacy of Vitamin B Complex in Critically Ill Obstetrics After Caesarean Section

Start date: May 25, 2024
Phase: N/A
Study type: Interventional

We aim to investigate the value of vitamin B (B1, B6, B9, B12) on post-cesarean section analgesia in addition to the standard opioid-sparing multimodal regimen to achieve more robust analgesia with minimal side effects.

NCT ID: NCT06434714 Not yet recruiting - Cesarean Section Clinical Trials

Management of Postoperative Pain After Cesarean Delivery Using Bridge Auricular Percutaneous Nerve Field Stimulator

Start date: June 2024
Phase: N/A
Study type: Interventional

Post-cesarean section (CS) pain is commonly treated with acetaminophen, ibuprofen, and opioid medications as needed following delivery. About 300,000 women annually who were exposed to opioids after CS will go on to use opioids chronically. Reducing the quantity of post-CS opioids has been shown to decrease the amount of opioids used without compromising pain control. Bridge is a small device that sits on the outer ear and works similarly to a transcutaneous electrical nerve stimulation (TENS) unit to decrease pain sensation without medications. It has been shown to effectively reduce pain to decrease medication requirements after surgeries. This study aims to see if women receiving the Bridge device use need less pain medication than those without the device.

NCT ID: NCT06431568 Completed - Cesarean Section Clinical Trials

Ondansetron Prior Spinal Anaesthesia

Ondansetron
Start date: October 1, 2023
Phase:
Study type: Observational [Patient Registry]

Since Ondansetron is commonly used during cesarean deliveries to treat nausea and vomiting, this study will observe the correlation between ondansetron administration and effect on hemodynamics in order to confirm that the use of Ondansetron can reduce incidence of hypotension and bradycardia associated with spinal in cesarean section, and to identify the optimal timing and dose for administration.

NCT ID: NCT06423807 Recruiting - Cesarean Section Clinical Trials

Preoperative Ondansetron Lozenge for Prevention of Post-Spinal Shivering in Caesarean Section

Start date: May 21, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to estimate the role of ondansetron lozenge on prevention of post-spinal shivering in cesarean section.

NCT ID: NCT06418308 Not yet recruiting - Cesarean Section Clinical Trials

Intrathecal Dexmedetomidine vs Epinephrine

Start date: May 2024
Phase: Phase 4
Study type: Interventional

Several studies have shown that adding dexmedetomidine or epinephrine to single-dose spinal analgesia preparations improves the length and/or speed of onset of the sensory block and post-operative pain management without increased negative side effects. To date, however, no study has compared adjunctive intrathecal dexmedetomidine to adjunctive intrathecal epinephrine in single-dose spinal analgesia. The purpose of this study is to determine if adjunctive intrathecal dexmedetomidine is non-inferior to adjunctive intrathecal epinephrine in providing better single-dose spinal analgesia during cesarean section.

NCT ID: NCT06393192 Completed - Cesarean Section Clinical Trials

The Post Cesarean Section Analgesic Effect of Various Quadratus Lumborum Block Approaches

Start date: October 1, 2023
Phase:
Study type: Observational

included patients were divided into 4 groups and each group received a mode of post cesarian section analgesia and pain was assessed by visual analogue scale at rest and movement. 1. st group epidural analgesia 2. nd group Quadratus lumborum type 2 3. rd group Quadratus lumborum type 3 4. th group Quadratus lumborum type (2+3)

NCT ID: NCT06376058 Recruiting - Cesarean Section Clinical Trials

Chloroprocaine 1% Versus Ropivacaine 0,75% During Cesarean Section

annie-mariana
Start date: January 10, 2024
Phase: N/A
Study type: Interventional

This will be a prospective randomized study, aiming at comparing an intrathecal fixed dose of chloroprocaine 1% versus an intrathecal fixed dose of ropivacaine 0.75% in elective cesarean sections

NCT ID: NCT06359223 Not yet recruiting - Cesarean Section Clinical Trials

Effect of Coffee Consumption on Pain and Intestinal Motility After Caesarean Section:

Start date: April 20, 2024
Phase: N/A
Study type: Interventional

Purpose: It will be performed to minimize the problems that the mother and the newborn may experience in the postpartum period by eliminating the negative symptoms related to postpartum pain and delayed intestinal motility. Design: It will be conducted as a randomized controlled experimental study. Method: It will consist of women who had cesarean section surgery at Necmettin Erbakan University Faculty of Medicine Hospital between April and July 2024. The sample of the research; The sample will consist of women who meet the selection criteria and voluntarily agree to participate in the research. Considering the possible 10% data loss in randomized controlled studies, a total of 50 women, 25 in each group, were planned to be sampled. Data will be collected using a personal information form and visual pain scale (VAS). . Immediately before coffee application (6-12-18 hours after surgery), women's pain intensity and bowel motility will be evaluated. Women will then be asked to consume 100 ml of unsweetened caffeinated coffee at 6, 12 and 18 hours after surgery. 6,12,18. Half an hour after coffee consumption, women will be evaluated for pain using VAS. In the control group, no procedure will be applied and pain assessment will be made with VAS at the same hours. Conclusion: It is aimed to reduce the pain and increase intestinal motility of patients who consume coffee after cesarean section. Key Words: Caesarean Section, Coffee, Pain, Motility

NCT ID: NCT06357637 Recruiting - Cesarean Section Clinical Trials

Abdominal Circumference Measure in Caesarian Section

ACirCuS
Start date: December 1, 2023
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to evaluate preoperative measures of abdominal circumference in patients admitted for a cesarean section. The main questions it aims to answer are: - Can preoperative abdominal circumference predict patients with difficult spinal anesthesia - Can preoperative abdominal circumference predict the occurrence of maternal hypotension during cesarean section Participants will be examined preoperatively in terms of visibility and palpation of spinous processes, abdominal circumference will be measured in the supine and sitting positions with other clinical parameters. Spinal anesthesia will be performed by the same experienced anesthesiologist with a standardized procedure. The number of skin punctures, needle reorientations, traumatic Cerebrospinal fluid, need for a paramedian approach or failure will be recorded. Maternal blood pressure and vasopressor requirements will also be monitored.